SYH2053
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for SYH2053, covering 2025-04-04 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia [Phase 3]